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Purpose: Degenerative aortic valve disease (AVD) is a complex disorder that goes beyond valve itself,
also undermining aortic wall. We aimed to assess the ascending aortic mechanics with two-dimensional
speckle tracking echocardiography (2DSTE) in patients with aortic regurgitation (AR) and hypothesized
a relationship with degree of AR. Aortic mechanics were then compared with those of similarly studied
healthy controls and patients with aortic stenosis (AS); ﬁnally, we aimed to assess the prognostic signiﬁ-
cance of vascular mechanics in AVD. Methods: Overall, 73 patients with moderate-to-severe AR and 22
healthy subjects were enrolled, alongside a previously examined cohort (N = 45) with moderate-to-
severe AS. Global circumferential ascending aortic strain (CAAS) and strain rate (CAASR) served as
indices of aortic deformation; corrected CAAS was calculated as CAAS/pulse pressure (PP). Median clini-
cal follow-up was 438 days. Results: In patients with severe (vs. moderate) AR, CAASR (1.53  0.29/sec
vs. 1.90  0.62/sec, P < 0.05) and corrected CAAS (0.14  0.06%/mmHg vs. 0.19  0.08%/mmHg,
P < 0.05) were signiﬁcantly lower, whereas CAAS did not differ signiﬁcantly. Measurers of aortic
mechanics (CAAS, corrected CAAS, CAASR) differed signiﬁcantly (all P < 0.01) in patients with AS and
AR and in healthy subjects, with lower values seen in patients with AS. In follow-up, survival rate of AVD
patients with baseline CAASR >0.88/sec was signiﬁcantly higher (log rank, 97.4% vs. 73.0%; P = 0.03).
Conclusions: Quantitative measures of aortic mechanics were lower for AS patients, suggesting a more
signiﬁcant derangement of aortic elastic properties. In the context of AVD, vascular mechanics assess-
ment proved useful in gauging clinical prognosis. (Echocardiography 2016;33:1121–1130)
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Introduction:
Degenerative aortic valve disease (AVD) is highly
prevalent in developed countries1,2 and it is
increasing given the aging of the population.3
Transthoracic echocardiography is a widely avail-
able noninvasive exam, and it is the most com-
monly used imaging modality for detecting and
evaluating valvular heart disease.
Speckle tracking echocardiography uses stan-
dard B-mode images to track blocks of speckles
frame-to-frame, measuring dimensional length-
ening/shortening relative to baseline.4 This
method enables angle-independent calculations
of motion and deformation variables, such as
velocity, displacement, strain and strain rate, that
can be assessed in the longitudinal, radial and cir-
cumferential directions. Initially, the study was
conﬁned to left ventricle (LV), but with further
validation, scope was expanded to include other
cardiac chambers. Since 2008, use of two-dimen-
sional speckle tracking echocardiography
(2DSTE) has been demonstrated for examining
vascular walls,5,6 ﬁrst at abdominal aorta and
then along ascending7 and descending aorta,8
aortic arch,9 and carotid arteries.10 Vascular
mechanics similarly have been validated in vivo11
and in vitro,12 using sonomicrometry. Moreover,
an association of the collagen content of the ves-
sels and vascular mechanics has also been
proved, promoting aortic mechanics as a new
imaging surrogate of vascular stiffening.13
Degenerative AVD is currently viewed as a sys-
temic disease evoking changes in arterial wall
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rigidity and compliance, a concept borne out
mainly in aortic stenosis (AS).14,15 Although a
gold standard method of determining local vas-
cular stiffness has yet to be approved, our group
has recently shown7,16 the utility of 2DSTE for
this purpose in patients with degenerative AS.
The association of vascular mechanics and aortic
regurgitation (AR) is less established, but previous
studies17 do indicate that a reduction in aortic
distensibility hastens the need for aortic valve
replacement in patients with chronic AR.
The purposes of this 2DSTE study were to: (1)
assess circumferential ascending aorta strain
(CAAS) and strain rate (CAASR) in patients with
moderate-to-severe AR; (2) explore a potential
association between CAAS and CAASR, and the
severity of AR; (3) compare aortic mechanics in
patients with AR or AS, relative to healthy con-
trols; and (4) examine the prognostic signiﬁcance
of CAAS and CAASR in the setting of degenera-
tive AVD.
Materials and Methods:
Study Population:
A total of 73 consecutive patients with isolated
AR with vena contracta (VC) >3 mm from a sin-
gle laboratory were prospectively enrolled in a 3-
month study, conducted between December
2013 and February 2014. Isolated AR was
deﬁned as mean transvalvular pressure gradient
<20 mm Hg. AR in patients was considered sev-
ere if VC >6 mm, plus one of the following quan-
titative criteria:18,19 effective regurgitant oriﬁce
area (EROA) ≥30 mm2, regurgitant volume (R
Vol) ≥60 mL, diastolic ﬂow reversal in descending
aorta with end-diastolic velocity >20 cm/sec, or
time-velocity integral (TVI) of reverse ﬂow
>15 cm.
A cohort of 45 consecutive patients with an
indexed aortic valvular area (iAVA) ≤0.85 cm2/m2,
as previously detailed by our group,7 was also
included in this data analysis.
Additionally, we included 22 apparently
healthy subjects referred for echocardiography
due to suspected cardiac structural disease. These
subjects had a normal echocardiography and
electrocardiogram.
The study protocol was approved by Comiss~ao
Nacional de Protecc~ao de Dados (authorization
3611/2015) and by Faculdade de Medicina da
Universidade de Coimbra ethics committee (proto-
col reference CE—005/2014).
Clinical Data:
Data recorded for each patient at admission
included age, weight, height, and cardiovascular
risk factors (such as hypertension, diabetes, dys-
lipidemia, and smoking habits). Histories of acute
myocardial infarction, stroke, chronic kidney
disease, and congestive heart failure (HF) were
documented. Body surface area (BSA)20 and
body mass index (BMI)21 were estimated accord-
ing to applicable formula. Clinical status was
assessed in accord with the New York Heart Asso-
ciation (NYHA) classiﬁcation.22 Current medica-
tions were recorded.
Systemic Arterial Hemodynamics:
Systemic arterial pressure was measured using an
arm cuff sphygmomanometer simultaneously
with Doppler measurement of left ventricular
outﬂow tract (LVOT) stroke volume. Indexed sys-
temic arterial compliance (SAC) was calculated as
follows: SAC = SVI/PP, where SVI is stroke volume
index and PP is brachial pulse pressure.14 Total
vascular resistance (TVR) was estimated as fol-
lows: TVR = 80 9 MAP/CO, where MAP is mean
arterial pressure (i.e. diastolic pressure plus one-
third brachial pulse pressure) and CO is cardiac
output.23
Echocardiography:
Transthoracic echocardiography was performed
using a Vivid 7 (GE Healthcare, Horton, Norway)
cardiovascular ultrasound device, with a 1.7/
3.4 MHz tissue harmonic transducer. Complete
echocardiographic studies called for standard
views and techniques stipulated by established
guidelines.24 In addition, short-axis views of
ascending aorta, distal to sino-tubular junction,
2–3 cm above aortic valve, were obtained at a
frame rate >50 frames per second. Machine set-
tings were manually adjusted to optimize 2D aor-
tic wall tracings and 2DSTE grayscale deﬁnition.
All images were acquired at end-expiratory
apnea. Loops of three cardiac cycles were stored
digitally and analyzed off line using a customized
software package (EchoPAC 9.0, GE Healthcare,
Horton, Norway).
Aortic regurgitation assessment: The etiology
and mechanism of AR, either from aortic leaﬂets
disease or from aortic root dilatation, were ana-
lyzed. Assessment of AR severity was based on
the recommended integration of qualitative and
quantitative parameters,18,19 including VC
width, proximal isovelocity surface area (PISA)
method, diastolic ﬂow reversal in the descend-
ing aorta (end-diastolic velocity, TVI of the
reverse ﬂow, ratio of reverse to forward TVI),
and pressure half-time (PTH) of continuous-
wave (CW) Doppler.
Left ventricular assessment: Left ventricular
dimensions were acquired through a 2D long-
axis parasternal window, in accord with current
guidelines.25 The LV mass was calculated via
American Society of Echocardiography corrected
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formula and indexed for BSA. LV end-systolic and
end-diastolic volumes and LV ejection fraction
(LVEF) were assessed using the modiﬁed Simp-
son’s rule.25 LV cardiac index was calculated as
the product of heart rate and indexed stroke vol-
ume for BSA. Stroke volume was obtained by LV
outﬂow Doppler method as the product of LVOT
area and time-velocity integral.26 The calculation
of E/e’ ratio (e’ being an average of septal and
lateral walls in tissue Doppler imaging) was used
to estimate LV ﬁlling pressures.27
Global LV afterload and elastic properties of
aorta: Valvulo-arterial impedance (ZVA), as a
measure of global LV afterload, was calculated as
follows: ZVA = SAP + MG/SVI, where SAP is sys-
tolic arterial pressure and MG is mean transvalvu-
lar pressure gradient.14
The aortic stiffness index (b1) was calculated
as: b1 = ln(Ps/Pd)/(AsAd)/Ad,28 where Ps and Pd
are systolic and diastolic arterial pressures, and As
and Ad are M-mode-guided systolic and diastolic
ascending aortic diameters, 2–3 cm above aortic
valve. Ad was obtained as R wave peaked in
simultaneously recorded electrocardiograms, and
As was measured at maximal anterior aortic wall
motion. Aortic stiffness index (b2) was also
assessed using 2DSTE peak systolic circumferen-
tial strain according to the equation: b2 = ln(Ps/
Pd)/global CAAS.
5
Two-dimensional speckle tracking strain
echocardiography: The 2DSTE technique was
used to calculate regional and global thoracic
ascending aorta mechanics. With a line manually
drawn along inner aspect of aortic wall in short
axis, additional lines were automatically gener-
ated digitally at the outer aspect of vessel wall.
Due to the thinness of vascular walls, relative to
cardiac walls, region of interest width was
reduced to the minimal value allowable by soft-
ware, as previously suggested.29 The initial sys-
tolic frame generally served as the frame of
interest, to include maximal aortic wall expansion
and recoil. As suggested previously,8,30 aortic
wall was divided into six equidistant regions, all
similar in size. In each region, numeric expres-
sions of each 2DSTE variable represented mean
values calculated from all points in the segment.
These were color coded and shown as a function
of time throughout the cardiac cycle. The track-
ing process and conversion to Lagrangian strains
were performed off line, using dedicated soft-
ware (EchoPAQ 9.0). CAAS and CAASR were then
determined. The CAAS curve peak value was usu-
ally appeared in proximity to (late peak) aortic
valvular closure; global CAAS represented the
mean of the six segmental peak values. Corrected
CAAS was calculated as global CAAS/PP.30 CAASR
curves, as in previously published data,5,10
included a positive early systolic peak, with global
CAASR representing the mean of the six segmen-
tal peak values. Quantitative curves reﬂecting all
regions could be expressed for each 2DST
variable (Fig. 1).
The intra-observer and inter-observer variabil-
ity of CAAS and CAASR were assessed in 10%
randomly selected subjects from both AR and
control groups. These measurements were
repeated one month later by the same echocar-
diographer (LL) to assess intra-observer repro-
ducibility. Inter-observer reproducibility was
assessed by a second echocardiographer (MOS),
and all values were compared with those of the
ﬁrst study.
Follow-up:
Clinical follow-up was performed targeting the
following outcomes: all-cause mortality, cardio-
vascular (CV) mortality, aortic valve replacement
(AVR), and HF hospitalization. We also assessed a
combined endpoint of CV mortality, AVR, or HF
hospitalization.
Statistical Analysis:
Normality of continuous variables was tested by
histogram observation and Kolmogorov–Smirnov
test. Continuous variables were expressed as
mean  standard deviation and categorical vari-
ables as percentage. Student’s t-test or ANOVA
was applied for group comparisons. Individual
variables were checked for homogeneity of vari-
ance via Levene’s test. For categorical variables,
chi-square or Fisher’s exact tests were used as
appropriate.
Pearson’s correlation was used to analyze rela-
tionships betweenCAAS or CAASR and continuous
variables. Linear regression analysis was performed
thereafter to identify variables independently asso-
ciated with CAAS and CAASR. A ﬁnal multivariate
model was subsequently elaborated, assessing all
clinically relevant signiﬁcant (P < 0.25) variables
identiﬁed in univariate analysis.
To control effects of age and gender on vas-
cular mechanics, we also performed one-to-one
matching in comparing aortic mechanics in AR
and AS patients with healthy control subjects.
Based on stored images of 10% randomly
selected patients, intra- and inter-observer repro-
ducibility of CAAS and CAASR values were
assessed by intra-class correlation coefﬁcient
(ICC) and by coefﬁcient of variation (CoV).31
A receiver operating characteristic (ROC)
curve analysis was used to compute the discrimi-
natory power of CAASR to predict survival in AVD
patients. Cumulative survival curves were
constructed using Kaplan–Meier method, and
group comparisons relied on log-rank test.
1123
Vascular Mechanics in Aortic Valve Disease
A P-value <0.05 in two-tailed tests was consid-
ered statistically signiﬁcant. Statistical analysis
relied on standard software, speciﬁcally SPSS
v20.0 (SPSS Inc, Chicago, IL, USA), MedCalc
12.2.1 (freeware), and GraphPad Prism 5.00
(GraphPad Software, In, La Jolla, CA, USA).
Results:
Ascending Aortic Mechanics in AR:
Mean age of patients with AR was
72  10 years, with gender balance. In most
patients, the etiology of AR was either degenera-
tive or unclear/mixed. Mean values of global
CAAS, corrected global CAAS, and global CAASR
were 10.81  3.95%, 0.17  0.08%/mm Hg,
and 1.81  0.58/sec, respectively.
Patient stratiﬁcation by degree of AR (moder-
ate vs. severe): Baseline demographic data, pre-
vious cardiovascular histories, and medication
use were relatively balanced between groups
(Table I). Patients were also homogenous in
terms of SAC, although severe AR patients had
a higher PP and a lower TVR. Both groups also
displayed similar etiologies, aortic diameters,
and elastic proprieties (Table II). LV diastolic
dimension and volume were signiﬁcantly higher
in patients with severe AR, as were indexed LV
mass and SVI. However, values of LVEF, cardiac
index, and E/E’ ratio were similar for both
groups.
In analysis of ascending aortic mechanics, glo-
bal CAAS was similar in both groups, whereas
corrected global CAAS (0.14  0.06%/mmHg
vs. 0.19  0.08%/mmHg, P < 0.05) and global
CAASR (1.53  0.29/sec vs. 1.90  0.62/sec,
P < 0.05) were signiﬁcantly lower in patients
with severe AR (Table III).
Variability of vascular mechanics in AR: Global
CAASR correlated signiﬁcantly with VC width
(r = 0.35, P < 0.01) and with TVI of reverse
ﬂow (r = 0.44, P < 0.01) (Table IV). Multiple
linear regression analysis revealed an indepen-
Figure 1. Assessment of ascending aorta mechanics via 2DST echocardiography generated from short-axis view of aorta, 2–
3 cm above aortic valve: quantitative curves representing all regions in a control subject (A), in a patient with isolated AR (B) or iso-
lated AS (C). Peaks of CAAS (in proximity to aortic valvular closure) and CAASR (ﬁrst peak after ventricular systole) both assume
positive values due to expansion of vessel wall.
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dent association between E/E’ ratio and global
CAAS (b = 0.28, P = 0.04), when adjusted for
end-diastolic velocity of reverse ﬂow and cardiac
index (Table V). After adjustment for SAC, only
TVI of reverse ﬂow (b = 0.05, P < 0.01)
remained signiﬁcantly predictive of CAASR
(Table VI).
Ascending Aortic Mechanics in AR versus AS
versus Healthy Controls:
Aortic mechanics (CAAS, corrected CAAS, and
CAASR) differed signiﬁcantly in AS and AR and in
healthy control subjects (all P < 0.01) (Fig. 2).
Because mean age also differed signiﬁcantly
among groups (AS, 77  10 years; AR,
72  10 years; controls, 53  17 years;
P < 0.01), age- and gender-matched analysis
was conducted, with no change in outcome
(P < 0.01) (Table S1).
The b1 (AS, 7.25  4.42; AR, 4.05  2.90;
controls, 3.25  2.99) and b2 stiffness index (AS,
12.44  5.92; AR, 7.16  4.64; controls,
5.08  2.75) also differed signiﬁcantly by group
(P < 0.01). Unlike vascular mechanics, SAC
(P = 0.99) and TVR (P = 0.43) in all groups were
similar.
Agreement and Reproducibility:
Waveforms adequate for measuring CAAS and
CAASR were present in 778 (92.6%) of the 840
arterial segments evaluated. Results of intra-
observer variability assessment were as follows:
TABLE I
Baseline Information, Risk Factors, Medication, and Systemic Arterial Hemodynamics of AR Patients
Total AR
patients (n = 73)
Moderate AR
(n = 55)
Severe AR
(n = 18) P
Age (years) 71.5  9.5 71.9  9.7 70.2  9.0 0.48
Male gender (%) 42 (57.5) 30 (54.5) 12 (66.7) 0.37
BMI (kg/m2) 26.3  3.4 26.4  3.4 25.8  3.4 0.47
Cardiovascular risk factors and medical conditions
Hypertension (%) 57 (78.1) 13 (76.4) 15 (83.3) 0.75
Diabetes (%) 13 (17.8) 11 (20.0) 2 (11.1) 0.50
Dyslipidemia (%) 47 (64.4) 38 (69.1) 9 (50.0) 0.14
Smoker (%) 2 (2.7) 2 (3.6) 0 (0.0) 0.56
Ex-smoker (%) 5 (6.8) 3 (5.5) 2 (11.1) 0.59
Chronic kidney disease (%) 13 (17.8) 9 (16.4) 4 (22.2) 0.72
Previous MI (%) 9 (4.1) 8 (14.5) 1 (5.6) 0.44
Previous stroke (%) 3 (4.1) 2 (3.6) 1 (5.6) 0.58
Current CHF admission (%) 7 (9.6) 3 (5.5) 4 (22.2) 0.06
NYHA class
Class I (%) 44 (60.3) 36 (65.5) 8 (44.4) 0.08
Class II (%) 22 (30.1) 16 (29.1) 6 (33.3)
Class III (%) 7 (9.6) 3 (5.5) 4 (22.2)
Class IV (%) 0 (0.0) 0 (0.0) 0 (0.0)
Current medication:
ACE inhibitor (%) 33 (45.2) 26 (47.3) 7 (38.9) 0.54
ARB (%) 26 (35.6) 17 (30.9) 9 (50.0) 0.14
MRA (%) 5 (6.8) 4 (7.3) 1 (5.6) 0.64
CCB (%) 14 (19.2) 11 (20.0) 3 (16.7) 0.53
b-blockers (%) 30 (41.1) 21 (38.2) 9 (50.0) 0.38
Diuretics (%) 43 (58.9) 29 (52.7) 14 (77.8) 0.10
Statin (%) 35 (47.9) 27 (49.1) 8 (44.4) 0.73
Systemic arterial hemodynamics:
Systolic arterial pressure (mmHg) 138.1  16.9 137.6  16.2 139.4  18.2 0.72
Diastolic arterial pressure (mmHg) 72.6  14.2 76.0  12.3 62.1  15.1 <0.01
Pulse pressure (mmHg) 65.5  18.8 61.7  15.1 77.3  24.0 <0.01
Heart rate (bpm) 67.8  13.7 68.9  14.8 64.2  8.9 0.21
Systemic arterial compliance (mL/mmHg/m2) 0.68  0.30 0.67  0.30 0.71  0.29 0.66
Total vascular resistance (mmHg min/L) 1748.2  640.3 1868.9  651.5 1351.7  413.0 <0.01
Bold values represent statistically signiﬁcant differences. AR = aortic regurgitation; BSA = body surface area; BMI = body mass
index; MI = myocardial infarction; CHF = congestive heart failure; NYHA = New York Heart Association; ACE = angiotensin con-
verting enzyme; ARB = angiotensin II receptor blocker; MRA = mineralocorticoid receptor antagonists; CCB = calcium channel
blockers.
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global CAAS, ICC = 0.96 (95% CI, 0.84–0.99),
and CoV = 6.9%; global CAASR, ICC = 0.96
(95% CI, 0.85–0.99), and CoV = 7.4%. In assess-
ing inter-observer variability, results were as fol-
lows: global CAAS, ICC = 0.89 (95% CI, 0.60–
0.98), and CoV = 10.4%; global CAASR,
ICC = 0.90 (95% CI 0.64–0.98), and
CoV = 10.5%.
TABLE II
Aortic Regurgitation Etiology and Severity, LV Geometry and Function, Aortic Diameters and Elastic Properties
Total AR patients
(n = 73)
Moderate AR
(n = 55)
Severe
AR (n = 18) P
AR etiology
Degenerative (%) 14 (19.2) 10 (18.2) 4 (22.2) 0.15
Bicuspid aortic valve (%) 2 (2.7) 1 (1.8) 1 (5.6)
Cusp rupture (%) 1 (1.4) 0 (0.0) 1 (5.6)
Aortic root pathology (%) 13 (17.8) 8 (14.5) 5 (27.8)
Unclear mechanism (%) 43 (58.9) 36 (65.5) 7 (38.9)
AR severity
Vena contracta width (mm) 5.0  1.6 4.3  0.7 7.3  1.3 <0.01
EROA (mm2) 28.2  15.5 20.3  7.1 39.9  17.5 <0.01
R Vol (mL) 61.5  38.8 39.8  15.0 92.4  41.7 <0.01
End-diastolic velocity of the reversal ﬂow (cm/sec) 11.0  7.3 9.4  7.2 14.9  6.0 <0.01
TVI of the reversal ﬂow (cm) 13.8  5.6 12.3  4.5 17.4  6.4 <0.01
Ratio of reversal to forward TVI 1.2  0.6 1.1  0.6 1.4  0.7 0.16
PTH of CW Doppler AR jet (ms) 435.6  141.3 471.0  129.8 285.1  73.6 <0.01
LV assessment
LV diastolic dimension (mm) 57.8  7.9 56.3  7.5 62.4  7.7 <0.01
LV systolic dimension (mm) 39.7  9.1 38.6  9.0 42.9  8.8 0.09
LV EDV indexed (mL/m2) 76.8  28.0 72.1  35.5 91.0  31.3 0.01
LV ESV indexed (mL/m2) 35.0  21.9 32.6  21.5 42.1  22.4 0.11
LVEF biplane (%) 56.2  11.6 56.3  12.1 55.8  10.3 0.87
LV mass indexed (g/m2) 72.7  20.2 68.7  18.7 83.7  20.8 0.01
Stroke volume index (mL/m2) 42.0  14.9 39.2  14.1 51.1  14.2 <0.01
Cardiac index (L/min/m2) 2.8  1.1 2.7  1.2 3.2  1.0 0.11
E/E’ ratio 11.9  5.3 12.2  5.5 10.5  4.5 0.30
LA volume indexed (mL/m2) 39.0  17.1 38.1  17.0 41.8  17.6 0.44
Valvulo-arterial impedance (mmHg/mL/m2) 3.9  1.4 4.1  1.5 3.1  1.0 <0.01
Aortic diameters
Valve annulus (mm) 34.9  4.9 34.8  4.5 35.5  6.1 0.62
Aortic sinus (mm) 36.8  5.6 36.4  5.3 38.3  6.3 0.25
Sinotubular junction (mm) 34.8  5.7 34.5  5.7 36.0  6.0 0.33
Proximal ascending aorta (mm) 39.4  5.9 39.0  5.6 40.5  6.7 0.40
Aortic elastic properties
Stiffness index b1 4.1  7.3 3.9  7.7 4.6  5.9 0.66
Stiffness index b2 7.2  4.6 6.8  4.6 8.3  4.8 0.24
Bold values represent statistically signiﬁcant differences. AR = aortic regurgitation; EROA = effective regurgitant oriﬁce area; R
Vol = regurgitant volume; TVI = tissue velocity index; PTH = pressure half-time; CW = continuous wave; LV = left ventricle;
EDV = end-diastolic volume; ESV = end-systolic volume; LVEF = left ventricular ejection fraction; LA = left atrium.
TABLE III
Circumferential Ascending Aortic Strain and Strain Rate
Total AR patients (n = 73) Moderate AR (n = 55) Severe AR (n = 18) P
Global CAAS (%) 10.81  3.95 10.91  4.22 10.50  3.10 0.72
Corrected global CAAS (%/mmHg) 0.17  0.08 0.19  0.08 0.14  0.06 <0.05
Global CAASR (/sec) 1.81  0.58 1.90  0.62 1.53  0.29 <0.05
Bold values represent statistically signiﬁcant differences. AR = aortic regurgitation; CAAS = circumferential ascending aorta strain;
CAASR = circumferential ascending aorta strain rate.
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Follow-Up Analysis:
Data were available for all 118 patients with AVD,
who were followed for a median period of 438
(IQR 386–539) days. During this time, global
mortality was 16.1% and CV mortality was
10.2%. Global CAAS, corrected global CAAS, and
global CAASR were signiﬁcantly lower in all-cause
or CV mortality subsets (Table VII).
A CAASR cutpoint of 0.88/sec showed 83.3%
sensitivity and 73.5% speciﬁcity for estimating
global mortality in patients with degenerative
AVD during follow-up (AU = 0.79, 95% CI: 0.66–
0.93, P < 0.01). Patients with a baseline global
CAASR > 0.88/sec had a signiﬁcant higher sur-
vival rate (97.4% vs. 73.0%, log-rank P = 0.03)
(Fig. 3).
Discussion:
Based on 2DSTE study, the following were
demonstrated: (1) high feasibility and repro-
ducibility of global CAAS and CAASR determina-
tions in patients with moderate-to-severe AR; (2)
signiﬁcantly lower global CAASR, albeit not glo-
bal CAAS, in patients with severe (vs. moderate)
AR; (3) independent associations between global
CAAS and E/E’ ratio and between global CAASR
and TVI of reverse ﬂow in patients with AR; (4)
signiﬁcant differences in aortic mechanics (CAAS,
corrected CAAS, and CAASR) in AS and AR and in
the control subjects; and (5) the clinical prognos-
tic signiﬁcance of aortic mechanics in degenera-
tive AVD.
Moderate-to-Severe AR:
To the best of our knowledge, this is the ﬁrst
effort to examine the utility of quantifying
ascending aortic mechanics by 2DSTE in patients
with AR. In our prior report on patients with AS,
SVI emerged as the most important determinant
of CAAS,7 whereas stiffness index b1 was strongly
associated with CAASR,16 suggesting that the
rate of circumferential vascular deformation
depends more on local arterial wall properties
and is less inﬂuenced by systolic ﬂow.
The concept that degenerative AVD alters
arterial wall rigidity and compliance is also valid
in the setting of AR. In patients with severe AR,
higher vascular load and lower global CAASR
were evident, likely reﬂecting more advanced
arteriosclerosis. Wilson et al17 demonstrated that
a decrease in distensibility of aorta imposes a
higher afterload and may contribute to deterio-
ration of chronic heart failure over time.
In instances of severe AR, higher SVI (due to
increased regurgitant volume) is balanced by sig-
niﬁcant impairment of vascular elastic properties,
perhaps explaining why global CAAS does not
differ substantially by grade (moderate vs. severe)
of AR. The corrected CAAS, which includes also
TABLE IV
Correlations with Global CAAS and Global CAASR
Variables
Global CAAS Global CAASR
r P value r P-Value
Age (years) 0.79 0.54 0.11 0.42
Systemic arterial
hemodynamics
Systolic arterial
pressure (mmHg)
0.01 0.93 0.03 0.83
Systemic arterial
compliance
(mL/mmHg/m2)
0.10 0.49 0.17 0.25
Total vascular
resistance
(mmHg min/L)
0.02 0.92 0.11 0.45
AR severity
Vena contracta
width (mm)
0.15 0.26 0.35 <0.01
End-diastolic
velocity of
the reversal
ﬂow (cm/sec)
0.18 0.20 0.24 0.10
TVI of the reversal
ﬂow (cm)
0.03 0.81 0.44 <0.01
LV assessment
LVEF biplane (%) 0.12 0.34 0.04 0.79
Cardiac index
(L/min/m2)
0.23 0.10 0.07 0.64
E/E’ ratio 0.16 0.25 0.03 0.86
Aortic elastic properties
Stiffness index b1 0.01 0.99 0.08 0.56
Bold values represent statistically signiﬁcant differences.
TABLE V
Linear Regression Model to Predict Global CAAS in AR
Variables b T value P-Value
E/E’ ratio 0.28 2.01 0.04
End-diastolic velocity of the
reversal ﬂow (cm/sec)
0.11 1.56 0.13
Cardiac index (L/min/m2) 0.80 1.75 0.09
Bold values represent statistically signiﬁcant differences.
B0 = 7.3 (P < 0.01); F 3.0 (P < 0.05); R
2 = 0.23.
TABLE VI
Linear Regression Model to Predict Global CAASR in AR
Variables b T value P-Value
TVI of the reversal ﬂow (mm) 0.05 2.29 <0.01
Systemic arterial compliance
(mL/mmHg/m2)
0.43 1.86 0.07
Bold values represent statistically signiﬁcant differences.
B0 = 2.7 (P < 0.01); F 5.7 (P < 0.01); R
2 = 0.26.
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the PP, was signiﬁcantly different in moderate
versus severe AR patients.
Comparing to the other aortic elastic propri-
eties analyzed (b1 and b2 stiffness index) which
did not signiﬁcantly differ by AR severity, CAASR
and corrected CAAS seemed to be more sensitive
parameters.
AR versus AS versus Healthy Controls:
Aortic mechanics (CAAS, corrected CAAS and
CAASR) derived from 2DSTE images differed
signiﬁcantly in AS, AR, and healthy subjects, even
after age and gender matching. These parame-
ters were lower in patients with AS, so in this con-
text, elastic properties of aorta are seemingly
altered to a signiﬁcantly greater extent. The
groups also differed signiﬁcantly in b1 and b2
stiffness index, although not in terms of SAC and
TVR, supporting the hypothesis that vascular
differences are mainly localized.
In an investigation by Petrini et al,32 trans-
esophageal echocardiography was performed in
patients with isolated severe AS or AR, all prior to
surgery in the operating room. Images of
descending aorta were analyzed using software
developed expressly for speckle tracking imaging
(VVI; Siemens Healthcare, Erlangen, Germany),
thus enabling automatic frame-by-frame record-
ing of area change, with VVI strain corresponding
to maximal systolic circumferential strain. Strain
was considerably higher in patients with AR than
in those with AS, which corroborates our
ﬁndings.
Figure 2. Ascending aorta mechanics in patients with AS and AR and in control subjects: comparisons by global CAAS (A), cor-
rected global CAAS (B), and global CAASR (C).
TABLE VII
Follow-up Data Regarding Ascending Aortic Mechanics
Global
CAAS (%)
Corrected
global CAAS
(%/mmHg)
Global
CAASR
(/sec)
Global mortality
Yes (n = 19) 6.99  4.05 0.11  0.06 0.86  0.50
No (n = 99) 9.30  4.15 0.16  0.08 1.45  0.70
P value 0.03 0.04 <0.01
Cardiovascular
mortality
Yes (n = 12) 6.45  3.38 0.09  0.04 0.77  0.44
No
(n = 106)
9.23  4.21 0.15  0.08 1.42  0.70
P value 0.03 0.02 <0.01
Aortic valve
replacement
Yes (n = 17) 7.70  3.55 0.14  0.08 0.99  0.45
No
(n = 101)
9.13  4.29 0.15  0.08 1.41  0.73
P value 0.21 0.52 0.03
Heart failure
hospitalization
Yes (n = 19) 6.93  3.72 0.13  0.09 1.08  0.72
No (n = 99) 9.34  4.20 0.15  0.08 1.40  0.69
P value 0.02 0.33 0.06
Combined
end point
Yes (n = 29) 7.21  3.87 0.12  0.08 1.08  0.66
No (n = 89) 9.52  4.17 0.16  0.08 1.44  0.70
P value 0.01 0.08 0.02
CAAS = circumferential ascending aorta strain; CAASR = cir-
cumferential ascending aorta strain rate.
Figure 3. Patient survival in follow-up, stratiﬁed by global
CAASR cut point (0.88/sec).
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Clinical Prognostic Signiﬁcance of Aortic
Mechanics:
In degenerative AS, it is acknowledged that LV
afterload increases due not only to valvular
obstruction but also to increased vascular load.33
Reduction in arterial compliance as a conse-
quence increased vascular stiffness then con-
tributed to LV burden, culminating in adverse
clinical events.14 This relationship with vascular
load has also been reported in the setting of AR,
linking decreased distensibility with faster pro-
gression to surgery.17
According to our exploratory analysis, aortic
mechanics seems to have a prognostic impact in
patients with degenerative AVD. Lower values of
global CAAS, corrected global CAAS, and global
CAASR showed signiﬁcant associations with
higher global mortality and CV death, with lesser
differences found for AVR and HF hospitalization
endpoints. In long-term follow-up, a signiﬁcant
relationship between CAASR >0.88/sec and
global mortality was also demonstrable.
Limitations:
This was a single-center study, based on a rela-
tively small patient sampling (N = 140). Rather
than monitoring central blood pressure, brachial
pressures were recorded, which typically are
overestimated. Furthermore, no invasive data on
cardiac output, total systemic resistance, or sys-
temic vascular compliance were available.
Although age disparity among groups was
potentially problematic, outcomes of age- and
gender-matched subgroup analysis upheld our
initial ﬁndings. The incremental value of 2DSTE
aortic mechanics in AVD evaluation, in addition
to conventional methods, was not assessed. Fur-
ther studies should be designed to explore it.
Conclusions:
In patients with AVD, use of 2DSTE to assess
ascending aortic mechanics was feasible and
proved highly reproducible. Global CAASR was
signiﬁcantly lower in patients with severe (vs.
moderate) AR, and measured parameters indi-
cated signiﬁcantly greater impairment of aortic
elastic properties in patients with AS. The prognos-
tic inﬂuence of ascending aortic mechanics in AVD
was also demonstrable, underscoring the value of
studying the vascular component with 2DSTE.
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